Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia

BACKGROUND: Thrombocytopenia is a common complication in cancer patients undergoing chemotherapy. Chemotherapy-induced thrombocytopenia (CIT) leads to dose reduction and treatment delays, lowering chemotherapy efficacy and survival rate. Thus, rapid recovery and continuous maintenance of platelet co...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jiwon, Kim, Min-Jung, Quan, Xingguo, Kim, Ji Woong, Lee, Sukmook, Park, SaeGwang, Jeong, Jee-Yeong, Yea, Kyungmoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230746/
https://www.ncbi.nlm.nih.gov/pubmed/37259024
http://dx.doi.org/10.1186/s12885-023-10975-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230746/
https://www.ncbi.nlm.nih.gov/pubmed/37259024
http://dx.doi.org/10.1186/s12885-023-10975-3

Ejemplares similares